TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.30$ +0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow UPB
Line item 2022 2023 2024 2025
+757.1% +48.3% -1,576.4%
+167.9% +75.2% +72.1%
-226.2% -68.6%
+75.6% +254.9% -67.7%
+100,926.8% -28.2% +57.1%
+1,200.3% +223.4% -99.4%
+3,319.0% -174.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?